Professor Mark Hulett from the La Trobe Institute for Molecular Science (LIMS), in collaboration with researchers from the University of New South Wales and The University Sydney, has been awarded a MRFF Grant to help fund development of strategies to reduce cardiac damage following a heart attack.
Their research will examine if it possible to prevent a second heart attack by reducing inflammation in the patient’s heart cells and tissues.
Heart attack survivors are at higher risk of having a second, often fatal, heart attack due to increased inflammation. While reducing inflammation reduces the chance of this happening, it also decreases the body’s ability to fight infection.
Professor Hulett, one the team’s Lead Chief Investigators said, “We are aiming to develop novel targeted therapies to reduce inflammation in the cells and tissues associated with the heart in order to prevent an often fatal second heart attack.
“I look forward to collaborating with the outstanding multidisciplinary team on this exciting project, which has the potential to make a paradigm shift in the treatment of heart attack patients”.
According to the Heart Foundation more Australians die of heart disease than any other cause. The need for therapies to prevent fatalities in cardiac patients is part of elevating the health and wellbeing of our society.